Similar Articles |
|
The Motley Fool April 27, 2011 Arundhati Parmar |
Medtronic and Eli Lilly Join Hands to Combat Parkinson's Disease The partnership aims to research and develop a new approach to treating the debilitating disease. |
Chemistry World October 24, 2013 Emily James |
Parkinson's protein holds clue to oxidative stress Scientists from the UK have identified a possible cause for the oxidative stress found in patients with Parkinson's disease. |
Managed Care September 2005 Thomas Morrow |
Dual-Treatment Approach to Parkinson's Disease The treatment of Parkinson's disease is complicated. Patients may benefit from a dual approach that uses medical therapy with new innovative treatment systems. |
BusinessWeek April 22, 2010 Rob Waters |
Gene Therapy Takes a Turn for the Better Researchers and investors are heartened by advances in gene therapy. Analysts say revenues are still several years off, however. |
American Family Physician December 15, 2006 |
Parkinson's Disease: What You Should Know What is Parkinson's disease?... How can I tell if I have Parkinson's disease?... How will my doctor know if I have it?... How is Parkinson's disease treated?... etc. |
Chemistry World October 2, 2007 Jonathan Edwards |
Light Shed on Parkinson's Culprit European scientists have developed a new technique to detect attogram quantities of iron in living cells -- providing further evidence of the role the metal plays in Parkinson's disease. |
American Family Physician December 15, 2006 Rao et al. |
Parkinson's Disease: Diagnosis and Treatment Family physicians should have a good understanding of Parkinson's disease because of its increasing prevalence as the population ages. Treatment should be individualized to decrease symptoms while minimizing motor and nonmotor complications. |
BusinessWeek May 24, 2004 |
Michael J. Fox's Take on Stem Cells Opposition to this research is "ridiculous," says the actor. It will happen "in other countries now, and we won't have as much input" |
The Motley Fool August 16, 2005 Karl Thiel |
New Life for Boston Life Sciences? The biotech's stock soars on news of potential approval of its imaging agent for Parkinson's and ADHD. Enthusiastic retail investors drove this week's huge move on the market, and those are the only folks who will be moving the stock for some time to come. |
AskMen.com December 12, 2014 Mark Hom |
Slowing The Aging Process Eating right and exercising can help you live longer. |